拮抗结缔组织生长因子小分子化合物的研究进展

中国药物警戒 ›› 2018, Vol. 15 ›› Issue (2): 98-102.

拮抗结缔组织生长因子小分子化合物的研究进展

刘俊丽, 张沐新, 梁迪, 郑明昕, 周小平^*

吉林大学药学院药物化学教研室，吉林长春 130021

收稿日期:2017-12-27 修回日期:2018-03-28 出版日期:2018-02-20 发布日期:2018-03-28
通讯作者: 周小平，女，博士，副教授，药物化学研究与教学。E-mail:zhouxp@jlu.edu.cn
作者简介:刘俊丽，女，在读硕士，药物化学。
基金资助:
国家自然科学基金项目（31270851）：重组谷胱甘肽过氧化物酶及其双功能抗氧化酶的筛选与表达；吉林省卫生计生委项目（2016J063）：具有抗癌作用的分蘖葱头多糖的研究；吉林省科技发展计划项目（20180414075GH）：COX/5-LOX多靶点抑制剂的合成及其抗肝纤维化作用研究。

Research Progress on Small-molecule Compounds against Connective Tissue Growth Factor

LIU Jun-li, ZHANG Mu-xin, LIANG Di, ZHENG Ming-xin, ZHOU Xiao-ping^*

Department of Medicinal Chemistry, School of Pharmacy, Jilin University, Jilin Changchun 130021, China

Received:2017-12-27 Revised:2018-03-28 Online:2018-02-20 Published:2018-03-28

摘要/Abstract

摘要： 目的对拮抗结缔组织生长因子（CTGF）小分子化合物进行综述和分析。方法对近年来国内外发表的针对现有的药物和新型结构类型化合物研究能够拮抗CTGF的小分子化合物的文献进行总结与分析。结果拮抗CTGF的小分子化合物的研究可以分为两个部分：一部分是针对现有的药物或天然产物展开的；另一部分是一系列不同结构类型的小分子化合物。结论 CTGF作为生物体内重要的细胞因子，只在间质细胞中表达，主要介导TGF-β的促纤维化作用，是一个更有效和特异的抗纤维化作用的靶点，虽然仅有几种结构类型，但是也开启了能够拮抗CTGF小分子化合物研究的序幕。

关键词: 结缔组织生长因子, 组织纤维化, 小分子化合物

Abstract: Objective To provide a concise overview of small molecule connective tissue growth factor (CTGF) inhibitors. Methods A summarization of the small molecules was provided, both the approved drugs and the agents under developing with new structures, that can inhibit CTGF. Results The research on small molecule CTGF inhibitors could be mainly classified into two categories: one is based on the approved drugs or natural products, the other is the small molecule compounds with new structures. Conclusion As a very important cytokine which is only expressed in interstitial cells, CTGF, inducing the fibrosis of TGF-β, is an effective and specific target for anti-fibrosis cytokine in organism. There are only a few structural types of compounds reported, but they will also be the prelude to provide useful references for developing more potential small molecule CTGF inhibitors in the future.

Key words: connective tissue growth factor, tissue fibrosis, small-molecule compound

中图分类号:

R965

刘俊丽, 张沐新, 梁迪, 郑明昕, 周小平. 拮抗结缔组织生长因子小分子化合物的研究进展[J]. 中国药物警戒, 2018, 15(2): 98-102.

LIU Jun-li, ZHANG Mu-xin, LIANG Di, ZHENG Ming-xin, ZHOU Xiao-ping. Research Progress on Small-molecule Compounds against Connective Tissue Growth Factor[J]. Chinese Journal of Pharmacovigilance, 2018, 15(2): 98-102.

参考文献

[1] Bradham D M, Igarashi A, Potter R L. Connective tissue growth factor: a cystine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10[J]. J Cell Biol, 1991, 114(6): 1285-1294.
[2] Moussad E E, Brigstock D R. Connective tissue growth factor: what's in a name?[J]. Mol Genet Metab, 2000, 71(1/2): 276-292.
[3] Gressner O A, Gressner A M. Connective tissue growth factor: a fibrogenic master swith in fibrotic liver diseases[J]. Liver International, 2008, 28(8): 1065-1079.
[4] Melennan S V, Abdollahi M, Twigg S M. Connective tissue growth factor, matrix regulation, and diabetic kidney disease[J]. Curr Opin Nephrol Hyperten, 2013, 22(1): 85-92.
[5] Shi-Wen X, Leask A, Abramham D J. Regulation and function of connectivetissuegrowth factor/CCN2 intissue repair, scarring and fibrosis[J]. Cytokine & Growth Factor Reviews, 2008, 19(2): 133-144.
[6] Ahmad A, Ahmad R. Understanding the mechanism of hepaticfibrosis and potential therapeutic approaches[J]. Saudi J Gastroenterol, 2012, 18(3): 155-167.
[7] Gao R, Brigstock D R. Low density lipoprotein receptor-relatedprotein (LRP) is a heparin-dependent adhesion receptor for conn-ectivetissue growth factor (CTGF) in rat activated hepatic stellate cells [J].Hepatol Res, 2003, 27(3): 214-220.
[8] Ozaki S, Sato Y, Yasoshima M, et al. Diffuseexpression of heparan sulfate proteoglycan and connective tissuegrowth factor in fibrous septa with many mast cells relate tounresolving hepatic fibrosis of congenital hepatic fibrosis [J]. LiverInternational, 2005,25(4): 817-828.
[9] Yang M, Huang H, Li J, et al. Tyrosine phosphorylation of the LDL receptor-related(LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation [J]. FASEB J, 2004,18(15): 1920-1921.
[10] Huang G, Brigstock D R, Integrin expression and function in the response of primary culture hepatic stellate cells to connective tissue growth factor(CCN2) [J]. Journal of cellular and molecular medicine, 2011,15(5): 1087-1095.
[11] Chen Y, Segarini P, Raoufi F, et al. Connective tissue growth factor is secreted through the Golgi and is degraded in the endosome[J]. Exp Cell Res, 2001,271(1): 109-177.
[12] Chen M M, Lam A, Abraham J A, et al.CTGFexpression is induced by TGF-beta in cardiac fibroblastsand cardiac my ocytes:a potential role in heart fibrosis[J].J Mol Cell Cardiol, 2000, 32(10):1805-1819.
[13] Piao R L, Brigstock D R, Zhu J, et al. Clinical significanceof connective tissue growth factor in hepatitis B virus－inducedhepatic fibrosis[J]. World J Gastroenterol, 2012, 18(18): 2280-2286.
[14] Julia R, Louis P S, Gerhard E, et al. 4-Dechloro-14-deoxy-oxacyclododecindione and 14-deoxy-oxacylododecindione, two inhibitors of inducibleconnective tissue growth factor expression from the imperfect fungus Exserohilum rostratum[J]. Bioorangic & Midicinal Chemistry, 2015, 23(3): 556-563.
[15] Gerhard E, Hanane B, Annegret S, et al. Oxacyclododecidione, a novel inhibitor of IL-4 signaling from Exserohilum rostratum[J]. Antibiotics, 2008, 61(5): 285-290.
[16] Kim K H, Park G T, Lim Y P, et al. Expression of connective tissue growth factor, a biomarkerin senescence of human diploid fibroblasts, is up-regulated bya transforming growth factor-β-mediated signaling pathway[J]. Biochemical and Biophysical Research Communications, 2004, 318(4): 819-825.
[17] Allen S, Andrews S W, Baer B, et al. 1-((3S, 4R)-4-(3-fluorophenyl)-1-(2-metho- xyethyl)pyrrolidin-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor: WO, 2015175788 A1[P]. 2015-11-19.
[18] Seno K, Shinosaki T. CTGF expression inhibitor: EP, 1839655 A1 [P]. 2007-10-03.
[19] 冯彦华,肖莉, 万宏光, 等. 辛伐他汀对肺纤维化大鼠肺内结缔组织生长因子表达的影响[J]. 中国医科大学学报, 2010, 39(9): 719-723.
[20] Watts K L, Sampson E M, Schultz G S, et al. Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts [J]. Am J Respir Cell Mol Biol, 2005, 32(4): 290-300.
[21] Tan A, Levrey H, Dahm C, et al. Lovastatin induces Fibroblast Apoptosis In Vitro and In Vivo: A Possible Therapy for Fibroproliferative Disorders[J]. Am J Respair Crit Care Med, 1999, 159(1): 220-227.
[22] Oh Y. Methods and compositions for treatment of tumor metastasis: US, 20120156216 A1 [P]. 2012-06-21.
[23] Hitoshi Y, Shigeki K, Ryuichi N, et al. Angiotensin-II and vascular endothelial growth factor interaction plays an imporment role in rat liver fibrosis development[J]. Hepatology Research, 2006, 36(2): 124-129.
[24] 黄颂敏, 刘芳, 刘小菁,等. 血管紧张素Ⅱ及其受体拮抗剂在系膜细胞培养中对结缔组织生长因子表达的影响[J]. 肾脏病与透析肾移植杂志, 2000, 9(5): 420-423.
[25] 姜美华, 徐友平, 姚国乾,等. 缬沙坦对心肌成纤维细胞转化生长因子和结缔组织生长因子表达的影响[J]. 西部医学, 2013, 25(4): 493-497.
[26] 王文丽, 李孝生, 陈爽. 川芎嗪对肝星状细胞增殖及结缔组织生长因子表达的影响[J]. 中国生物制品学杂志, 2009, 22(1): 65-68.
[27] Hu J, Cao G, Wu X, et al. Tetramethylpyrazine Inhibits Activation of Hepatic Stellate Cellsthrough Hedgehog Signaling Pathways In Vitro [J]. BioMedResearch International, 2015: 603067/1-603061/6.
[28] Liang B, Guo X L, Jin J, et al. Glycyrrhizic acidinhibits apoptosis and fibrosis in carbon-tetrachloride-inducedrat liver injury[J]. World J Gastroenterol, 2015, 21(17): 5271-5280.
[29] Zheng S Z, Chen A. Curcumin suppresses the expression of extracellular matrix genes in activatedhepatic stellate cells by inhibiting gene expression of connectivetissue growth factor[J]. American Journal of Physiology, 2006, 290(5): G883-G893.
[30] Chen S R, Zhang W P, Bao J M, et al. Aristoyunnolin H attenuates extracellular matrix secretionin cardiac fibroblasts by inhibiting calcium influx [J]. Arch. Pharm. Res., 2017, 40(1): 122-130.